Schizoaffective Disorders
13
0
0
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
1 terminated out of 13 trials
90.9%
+4.4% vs benchmark
62%
8 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (13)
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.
Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder
A Comparative Study of New Medications for Psychosis in Adolescents